RxNews Recap on Friday 10-23-09 Print E-mail
By Mary Davila   
Saturday, 24 October 2009 09:28

biomedreportsBelow is a list of the companies that made news in the healthcare sector on Friday October 23, 2009.

Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.

Biovail Corporation (NYSE:BVF) announced it will host a conference call and webcast on Thursday, November 5, 2009 at 8:30a.m. for Company executives to discuss third-quarter 2009 financial and operational results.

avVaa World Health Care Products Inc. (OTC:AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeuticnatural skin and health care products, announced their third Direct TV Media Test is scheduled to launch on Thursday October 29.

Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced Fred W. Driscoll, VP and CFO, will be presenting at the 8th Annual BIO Investor Forum 2009 at 11:00 am local time on October 29, 2009 at the Palace Hotel in San Francisco, California.

Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Allergan, Inc. (NYSE:AGN) announced the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc.

Exelixis, Inc. (Nasdaq:EXEL) and Bristol-Myers Squibb Company (NYSE:BMY) reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

Columbia Laboratories, Inc. (Nasdaq:CBRX) announced it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering.

Biovail Corporation (NYSE:BVF) announced it will host a conference call and webcast on Thursday, November 5, 2009 at 8:30a.m. for Company executives to discuss third-quarter 2009 financial and operational results.

Lightlake Therapeutics Inc. (OTC:LLTP)
, a drug discovery company developing innovative solutions to combat the worldwide epidemic in obesity – a trillion dollar market - has appointed Dr Roger Crystal as CEO.

Ferro Corporation (NYSE:FOE) announced it will conduct a conference call on Tuesday, October 27, at 10:00 a.m. Eastern Time to discuss financial results for the three months ended September 30, 2009 and factors which are expected to affect the Company's future performance.

Mediware Information Systems, Inc. (NASDAQ:MEDW) announced the Blood Bank of Alaska is the latest major blood center to license LifeTrak®, the company's 510(k) cleared blood donor management software.

Inhibitex, Inc. (Nasdaq:INHX) announced it has entered into definitive purchase agreements with institutional investors for the sale of approximately $23 million of its common stock, and warrants to purchase common stock, in a private placement.

Advaxis, Inc., (OTC:ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, has announced the appointment of Christopher Duignan to the role of senior vice president, Finance, working alongside Advaxis CFO Fredrick Cobb, effective immediately.

Lpath, Inc. (OTC:LPTN), the category leader in therapeutic agents against bioactive lipids, will present at the 2009 BIOCOM Investor Conference, which will be held October 26-27, 2009 at the Hyatt Regency La Jolla in San Diego, California.

Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced it will report its financial results for the quarter ended September 30, 2009, on Wednesday, November 4, 2009.

Orthovita, Inc. (NASDAQ:VITA), an orthobiologics and biosurgery company, is pleased to announce Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, “A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial,” at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).

Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI), announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States.

Unilife Medical Solutions Limited (OTC:UNIFF) announced its Chief Executive Officer Alan Shortall has made open market purchases of Company shares.

Senetek PLC (OTC:SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies which target the science of healthy aging, announced it has engaged Miller Tabak + Co., LLC as exclusive financial advisor to assist the Board of Directors with a review of strategic options and development of a business plan to maximize the assets of the company.

Escalon Medical Corp. (Nasdaq:ESMC) announced its Sonomed, Inc. subsidiary's introduction of the new PacScan(TM) Plus, an A-Scan with optional pachymeter.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus